leisure time -WSS

leisure time

author：hotspot 2025-09-30 00:47:45 - browse：2

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Some medical students still think black patients feel less pain

hotspot

WSS

Research misconduct: Proposed new rules face resistance

Medicare Advantage today, explained in one chart

Copay coupons to count toward deductibles, after Biden court move

AI generated plenty of interest at JPM but not a lot of trust

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Parkinson’s finding may lead to tests and, someday, treatments

hotspot

leisure time

focus

Guidelines to prevent youth baseball injuries need more muscle

Clinicians often fail to acknowledge the pain caused by long Covid

In age of alternative facts, a scholarly course on calling out crap

EU regulator recommends expanding Mounjaro approval to obesity

Moonlake's readout produced a cash windfall. Risks remain

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Guardant Health colon cancer test endorsed by FDA advisory panel

United colonoscopy coverage change 'may cost lives,' doctors say

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

hotspot

Ozempic cut risk of death in diabetes patients with chronic kidney disease

New research sheds light on how often breast cancer is overdiagnosed

Achieving telehealth equity for people with hearing loss

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Unmasking the 'centricity' illusion in clinical trials

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

focus

focus

hotspot

hotspot